Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Gross Profit

Rigel Pharmaceuticals Gross Profit Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Gross Profit from 2010 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Rigel Pharmaceuticals Gross Profit for the quarter ending June 06, 2020 was $2m a -298.17% decrease of -5m year over year
  • Rigel Pharmaceuticals Gross Profit for the last 12 months ending June 06, 2020 was $48m a 40.84% increase of 20m year over year
  • Rigel Pharmaceuticals Annual Gross Profit for 2019 was $5m a 148.77% increase of 8m from 2018
  • Rigel Pharmaceuticals Annual Gross Profit for 2018 was $-3m a -1,458.56% increase of 39m from 2017
  • Rigel Pharmaceuticals Annual Gross Profit for 2017 was $-42m a -3.06% increase of 1m from 2016
Other Income Statement Metrics:
  • Rigel Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $3m a 1,013.58% increase of 27m year over year
  • Rigel Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $3m a 855.42% increase of 28m year over year
  • Rigel Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $5m a 26.33% increase of 1m year over year
View Chart On Koyfin

Quarterly RIGL Gross Profit Data

06/2020$2m
03/2020$39m
12/2019$1m
09/2019$6m
06/2019$-3m
03/2019$2m
12/2018$24m
09/2018$-6m
06/2018$-9m
03/2018$-11m

Annual RIGL Gross Profit Data

2019$5m
2018$-3m
2017$-42m
2016$-43m
2015$-34m
2014$-59m
2013$-68m
2012$-77m
2011$-65m
2010$77m